Launched in 2022, Advanced Research Clusters (ARC) was created through the merger of Brookfield's investments in the Harwell Science and Innovation Campus—a joint venture with the U.K. Government—and Arlington. ARC offers premier specialized real estate environments sought by science and technology organizations, bringing tenants together in clusters around major scientific and research hubs that stimulate innovation and accelerate commercial growth. 

Today, ARC’s portfolio comprises 1.6 million square feet of existing assets and 5 million square feet of development potential across the U.K.’s Golden Triangle.  ARC also provides us with a strong base from which to expand in the U.K. and Europe, benefiting from Brookfield’s global networks. With private and public capital flowing into the science, technology and innovation sectors, there is a tremendous opportunity to create centers of excellence that foster growth. 

Building platform businesses is part of Brookfield’s DNA and spans the breadth of our business from hydro and utilities to multifamily and student housing—and now life sciences. Our operating capabilities and flexible capital enable us to invest in a sector at its infancy, acquiring single assets or small portfolios, and rapidly building teams, operations and growth functions—as well as take development risk to create scaled, institutional-quality platforms.